Tofacitinib Impurity 36
- Product NameTofacitinib Impurity 36
- CAS2250241-69-9
- CBNumberCB53166559
- MFC13H11N3O3S
- MW289.31
- MDL NumberMFCD34603180
- MOL File2250241-69-9.mol
Chemical Properties
| Boiling point | 540.0±60.0 °C(Predicted) |
| Density | 1.49±0.1 g/cm3(Predicted) |
| pka | 0.90±0.20(Predicted) |
Tofacitinib Impurity 36 Price
| Product number | Packaging | Price | Product description | Buy |
|---|---|---|---|---|
| Synthonix T75533 | 250mg | $540 | 7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one ≥95% |
Buy |
| Synthonix T75533 | 1g | $1130 | 7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one ≥95% |
Buy |
| Synthonix T75533 | 5g | $2250 | 7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one ≥95% |
Buy |
| aablocks AA01XEZO | 100mg | $565 | 7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one ≥95% |
Buy |
| aablocks AA01XEZO | 250mg | $611 | 7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one ≥95% |
Buy |
Preparation Products And Raw materials
Tofacitinib Impurity 36 Suppliers
Global(19)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 0510-85629785 18013409632; |
sales@reading-chemicals.com | China | 15165 | 58 | |
| 15053191807 | sales_sanzhi@163.com | China | 286 | 55 | |
| 021-20242659 18930833303 |
sales@changyanchem.cn | China | 4998 | 55 | |
| 0755-28967200 13631290199 |
wxf@sungening.com | China | 9609 | 60 | |
| +8618071025641 | eric@witopchemical.com | China | 23504 | 58 | |
| +1-858-6993322 +86-18019713315 |
info@accelachem.com | United States | 21189 | 58 | |
| 2710913286@qq.com | 1513643261@qq.com | China | 14227 | 58 | |
| 021-50795510 4000665055 |
marketing@accelachem.com | China | 10452 | 58 | |
| 18569809817 | 2208093734@qq.com | China | 3989 | 58 | |
| +86-020-81960175-877 4000-868-328;4000-868-328 |
tianwen.zhan@cato-chem.com | United States | 10384 | 58 |
2250241-69-9, Tofacitinib Impurity 36Related Search
- Tofacitinib Impurity 2
- Tofacitinib Impurity 45
- Tofacitinib Related Compound
- (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
- N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide
- 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
- butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
- Tofacitinib Impurity
- N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
- 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- Tofacitinib Impurity
1of4
PROMPT×
PROMPT
The WhatsApp is temporarily not supported in mainland China
The WhatsApp is temporarily not supported in mainland China
Cancel
Determine